HOXA9 and acute myeloid leukemia: Considering that both Hoxa9 and Meis1 are currently considered undruggable, it is worth further deciphering the relationships between amino acid metabolism and leukaemogenesis in the KM to help develop amino acid disruption strategies for AML treatment.